1. Home
  2. ATRC vs SABR Comparison

ATRC vs SABR Comparison

Compare ATRC & SABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRC
  • SABR
  • Stock Information
  • Founded
  • ATRC 2000
  • SABR 2006
  • Country
  • ATRC United States
  • SABR United States
  • Employees
  • ATRC N/A
  • SABR N/A
  • Industry
  • ATRC Medical/Dental Instruments
  • SABR Computer Software: Programming Data Processing
  • Sector
  • ATRC Health Care
  • SABR Technology
  • Exchange
  • ATRC Nasdaq
  • SABR Nasdaq
  • Market Cap
  • ATRC 1.1B
  • SABR 1.3B
  • IPO Year
  • ATRC 2005
  • SABR 2014
  • Fundamental
  • Price
  • ATRC $38.39
  • SABR $4.52
  • Analyst Decision
  • ATRC Strong Buy
  • SABR Hold
  • Analyst Count
  • ATRC 10
  • SABR 4
  • Target Price
  • ATRC $49.50
  • SABR $3.25
  • AVG Volume (30 Days)
  • ATRC 539.4K
  • SABR 3.7M
  • Earning Date
  • ATRC 02-12-2025
  • SABR 02-20-2025
  • Dividend Yield
  • ATRC N/A
  • SABR N/A
  • EPS Growth
  • ATRC N/A
  • SABR N/A
  • EPS
  • ATRC N/A
  • SABR N/A
  • Revenue
  • ATRC $465,307,000.00
  • SABR $3,029,565,000.00
  • Revenue This Year
  • ATRC $14.41
  • SABR $6.34
  • Revenue Next Year
  • ATRC $12.87
  • SABR $5.08
  • P/E Ratio
  • ATRC N/A
  • SABR N/A
  • Revenue Growth
  • ATRC 16.55
  • SABR 4.19
  • 52 Week Low
  • ATRC $18.94
  • SABR $1.81
  • 52 Week High
  • ATRC $43.11
  • SABR $4.63
  • Technical
  • Relative Strength Index (RSI)
  • ATRC 47.41
  • SABR 78.07
  • Support Level
  • ATRC $37.72
  • SABR $3.39
  • Resistance Level
  • ATRC $42.68
  • SABR $3.60
  • Average True Range (ATR)
  • ATRC 1.78
  • SABR 0.19
  • MACD
  • ATRC -0.59
  • SABR 0.10
  • Stochastic Oscillator
  • ATRC 13.51
  • SABR 92.25

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

About SABR Sabre Corporation

Sabre holds the number-two air booking volume share in the global distribution system industry. The travel solutions segment represented 91% of total 2023 revenue, split between distribution (78% of segment sales) and airline IT solutions (22%) revenue. The company also has a growing hotel IT solutions division (9% of revenue). Transaction fees, which are mostly tied to volume and not price, account for the bulk of sales and profits.

Share on Social Networks: